Drugs Made In America Acquisition Corp.

DMAA
$10.65 (+ $0.01 + 0.09%)
Last updated: 2026-07-04 11:47 UTC
DMAA Metrics
Exchange
🇺🇸 NASDAQ XNMS
Nasdaq/NMS (Global Market)United StatesAmerica/New_York
SectorFinancial Services
IndustryShell Companies
ISINKYG2847J1040
Market Price10.65
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend FrequencyNone
P/E RatioN/A
EPSN/A
Market Cap$347.6M
Book Value-0.22
Price to Book-47.352
BetaN/A
52w High10.37
52w Low9.95
Next Earnings DateN/A

Drugs Made In America Acquisition Corp. trades under ticker DMAA on NASDAQ as a stock. Use this page to review stock price, dividends, and price history. The page also shows Financial Services exposure. Identifiers: ISIN KYG2847J1040.

About the Company
Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in Fort Lauderdale, Florida.
Price History